Andere talen Kyowa Kirin Co. Ltd.

Aandelen

4151

JP3256000005

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.656 ^JPY	+2,87%		+3,41%	+12,05%

07/05	Winst Kyowa Kirin 15% hoger in Q1	MT
02/05	Aandelen BridgeBio Pharma dalen na financiële resultaten Q1	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Kyowa Kirin's Profit Up 15% in Q1	07/05
BridgeBio Pharma Shares Decline After Q1 Financial Results	02/05
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease	08/04
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25/03
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25/03
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20/03
US approves first gene therapy for children with rare genetic disease	18/03
US approves first gene therapy for rare genetic disease	18/03
Kyowa Kirin Co., Ltd. to Present Phase 2B Post-Hoc Analysis and Symposium At the American Academy of Dermatology Annual Meeting 2024	08/03
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares	05/03
China Deflation, Bank of Japan Roil Asian Stock Markets	08/02
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar	08/02
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost	08/02
BridgeBio Pharma Unit to Grant Kyowa Kirin License for Infigratinib in Japan	07/02
Kyowa Kirin's Profit Up 52% in Fiscal 2023	07/02
Kyowa Kirin Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024	07/02
Kyowa Kirin Co., Ltd. Declares Dividend for the Fiscal Year Ended December 31, 2023, Payable on March 25, 2024; Provides Dividend Guidance for the Second Quarter of 2024	07/02
Kyowa Kirin Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2024	07/02
Kyowa Kirin Co., Ltd. announces an Equity Buyback for 17,000,000 shares, representing 3.16% for KRW 40,000 million.	07/02
Kyowa Hakko Kirin Co., Ltd. authorizes a Buyback Plan.	07/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kyowa Kirin Co. Ltd.

Aandelen

4151

JP3256000005

Andere talen

Filters